Non Iodine Avid Bone Metastasis from Differentiated Thyroid Cancer: A Case Series XR01-XR03
Dr. Sudheesh Manoharan,
Senior Resident, Department of Surgical Oncology, Malabar Cancer Centre, Kannur-670103, Kerala, India.
Differentiated Thyroid Carcinoma (DTC) constitute up to 90 per cent of all thyroid malignancy. The overall prognosis of patients with DTC is good, but when bone metastases are present, the overall survival at 10 years ranges from 13 to 21%. Treatment of metastatic thyroid cancer that are non iodine avid offers a surgical challenge. This paper reviews a series of three cases of DTCs with bone metastasis treated by surgery.